Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Kristen Kluska Maintained (XFOR) at Buy and Held Target at $3 on, Mar 22nd, 2023
Kristen Kluska of Cantor Fitzgerald, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Buy and Held Target at $3 on, Mar 22nd, 2023.
Kristen has made no other calls on XFOR in the last 4 months.
There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Kristen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kristen
- Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022
